A comparison of the effects of two anabolic agents (fluoride and PTH) on ash density and bone strength assessed in an osteopenic rat model

Bone

Volumn 20, Issue 5, 1997, Pages 439-449

  Søgaard, Charlotte Hasselholt ^a,d   Mosekilde, Li ^a   Thomsen, J S ^a   Richards, A ^b   McOsker, J E ^c  

^a AARHUS UNIVERSITY   (Denmark)

^b UNIVERSITY OF AARHUS   (Denmark)

^c PROCTER AND GAMBLE PHARMACEUTICALS   (United States)

^d NONE   (Denmark)

Author keywords

Bone quality; Bone strength; Fluoride; PTH; Rat

Indexed keywords

ANABOLIC AGENT; FLUORIDE; FLUORIDE SODIUM; PARATHYROID HORMONE[1-34];

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOMECHANICS; BONE DENSITY; BONE MASS; BONE MINERAL; BONE STRENGTH; CONTROLLED STUDY; CORTICAL BONE; DRUG EFFECT; FEMALE; FEMUR; FEMUR NECK; NONHUMAN; OSTEOPENIA; OVARIECTOMY; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; VERTEBRA BODY;

ANIMALS; BIOMECHANICS; BONE AND BONES; BONE DENSITY; BONE DISEASES, METABOLIC; FEMALE; FEMUR NECK; OVARIECTOMY; OVARY; PARATHYROID HORMONE; RATS; RATS, SPRAGUE-DAWLEY; SODIUM FLUORIDE; SPINE;

EID: 0030943087     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S8756-3282(97)00020-3     Document Type: Article

References (49)

1. Aerssens, J., Van Audekercke, R., Geusens, P., Schot, L. P. C., Osman, A. A-H., and Dequeker, J. Mechanical properties, bone mineral content, and bone composition (collagen, osteocalcin, IGF-1 ) of the rat femur: Influence of ovariectomy and nandrolone decanoate (anabolic steroid) treatment. Calcif Tissue Int 53:269-277; 1993.
2. Bagi, C. M., Mecham, M., Weiss, J., and Miller, S. C. Comparative morphometric changes in rat cortical bone following ovariectomy and/or immobilization. Bone 14:877-883; 1993.
3. Baumann, B. D. and Wronski T. J. Response of cortical bone to antiresorptive agents and parathyroid hormone in aged ovariectomized rats. Bone 16:247-253; 1995.
4. Baylink, D. J., Wergedal, J. E., Farley, J. R., and Einhorn, T. A. On fluoride and bone strength [letter to the editor]. Calcif Tissue Int 56:415-418; 1995.
5. Dambacher, M. A., Ittner, J., and Ruegsegger, P. Long-term fluoride therapy of postmenopausal osteoporosis. Bone 7:199-205; 1986.
6. Einhorn, T. A., Wakley, G. K., Linkhart, S., Rush, E. B., Maloney, S., Faierman, E., and Baylink, D. J. Incorporation of sodium fluoride into cortical bone does not impair the mechanical properties of the appendicular skeleton in rats. Calcif Tissue Int 51:127-131; 1992.
7. Eriksen, E. F., Hodgson, S. F., and Riggs, B. L. Treatment of osteoporosis with sodium fluoride. In: Riggs, B. L. and Melton, L. J., III, Eds. Osteoporosis: Etiology, Diagnosis and Management. New York: Raven; 1988; 415-432.
8. Gunness, M. and Hock, J. M. Anabolic effect of parathyroid hormone is not modified by supplementation with insulinlike growth factor 1 (IGF-I) or growth hormone in aged female rats fed an energy-restricted or ad libitum diet. Bone 16:199-207; 1995.
9. Gunness-Hey, M. and Hock, J. M. Increased trabecular bone mass in rats treated with human synthetic parathyroid hormone. Metab Bone Dis Rel Res 5:177-181; 1984.
10. Hefti, E., Treschel, U., Bonjour, J. P., Fleisch, H., and Schenk, R. Increase of whole body calcium and skeletal mass in normal and osteoporotic adult rats treated with parathyroid hormone. Clin Sci 62:389-396; 1982.
11. Hock, J. M., Gera, I., Fonseca, J., and Raisz, L. G. Human parathyroid hormone-(1-34) increases bone mass in ovariectomized and orchidectomized rats. Endocrinology 122:2899-2904; 1988.
12. Ibbotson, K. J., Orcutt, C. M., D'Souza, S. M., Paddock, C. L., Arthur, J. A., Jankowski, M. L., and Boyce, R. W. Contrasting effects of parathyroid hormone and insulin-like growth factor I in an aged ovariectomized rat model of postmenopausal osteoporosis. J Bone Miner Res 7:425-432; 1992.
13. Jee, W. S. S., Mon, S., Li, X. J., and Chan, S. Prostaglandin E2 enhances cortical bone mass and activates intracortical bone remodeling in intact and ovariectomized female rats. Bone 11:253-266; 1990.
14. Kalu, D. N. Evaluation of the pathogenesis of skeletal changes in ovariectomized rats. Endocrinology 115:507-512; 1984.
15. Kalu, D. N. The ovariectomized rat model of postmenopausal bone loss. Bone Miner 15:175-192; 1991.
16. Kalu, D. N., Echon, R., and Hollis, B. W. Modulation of ovariectomy-related bone loss by parathyroid hormone in rats. Mech Ageing Dev 56:49-62; 1990.
17. Kalu, D. N., Liu, C. C., Hardin, R. R., and Hollis, B. W. The aged rat model of ovarian hormone deficiency bone loss. Endocrinology 124:7-16; 1989.
18. Kanwar, K. C. and Dhar, S. Bone strength and fluoride supplementation. Zool J Physiol 93:145-148; 1989.
19. Kleerekoper, M. and Balena, R. Fluorides and osteoporosis. Ann Rev Nutr 11:309-324; 1991.
20. Kleerekoper, M. and Mendlovic, D. B. Sodium fluoride therapy of postmenopausal osteoporosis. Endocrine Rev 14:312-323; 1993.
21. Kleerekoper, M., Peterson, E. L., Nelson, D. A., Phillips, E., Schork, M. A., Tilley, B. C., and Parfitt, A. M. A randomized trial of sodium fluoride as a treatment for post-menopausal osteoporosis. Osteopor Int 1:155-161; 1991.
22. Li, M., Mosekilde, Li., Søgaard, C. H., Thomsen, J. S., and Wronski, T. J. Parathyroid hormone monotherapy an cotherapy with antiresorptive agents restore vertebral bone mass and strength in ovariectomized rats. Bone 16:629-635; 1995.
23. Li, M. and Wronski, T. J. Response of femoral neck to estrogen depletion and parathyroid hormone in aged rats. Bone 16:551-557; 1995.
24. Liu, C. C., Kalu, D. N., Salerno, E., Echone, R., Hollis, B. W., and Ray, M. Preexisting bone loss associated with ovariectomy in rats is reversed by parathyroid hormone. J Bone Miner Res 6:1071-1080; 1991.
25. McCann, H. G. Determination of fluoride in mineralized tissues using the fluoride ion electrode. Arch Oral Biol 13:475-477; 1968.
26. Melton, L. J., III. Fluoride in the prevention of osteoporosis and fractures. J Bone Miner Res 5(Suppl. 1):S163-S167; 1990.
27. Mosekilde, Li., Danielsen, C. C., and Gasser, J. The effects on vertebral bone mass and strength of long term treatment with anti resorptive agents (estrogen and calcitonin), human parathyroid hormone-(1-38), and combination therapy, assessed in aged ovariectomized rats. Endocrinology 134:2126-2134; 1994.
28. Mosekilde, Li., Danielsen, C. C., Søgaard, C. H., McOsker, J. E., and Wronski, T. J. The anabolic effects of parathyroid hormone on cortical bone mass, dimensions and strength - assessed in a sexually mature, ovariectomized rat model. Bone 16:223-230; 1995.
29. Mosekilde, Li., Danielsen, C. C., Søgaard, C. H., and Thorling, E. B. The effect of long-term exercise on vertebral and femoral bone mass, dimensions, and strength - assessed in a rat model. Bone 15:293-301; 1994.
30. Mosekilde. Li., Kragstrup, I., and Richards, A. Compressive strength, ash weight, and volume of vertebral trabecular bone in experimental fluorosis in pigs. Calcif Tissue Int 40:318-322; 1987.
31. Mosekilde, Li., Søgaard, C. H., Danielsen, C. C., Tørring, O., and Nilsson, M. H. L. The anabolic effects of human parathyroid hormone (hPTH) on rat vertebral body mass are also reflected in the quality of bone, assessed by biomechanical testing: A comparison study between hPTH-(1-34) and hPTH-(1-84). Endocrinology 129:421-428; 1991.
32. Mosekilde, Li., Søgaard, C. H., McOsker, J., and Wronski, T. J. PTH has a more pronounced effect on vertebral bone mass and biomechanical competence than antiresorptive agents (estrogen and bisphosphonates) - assessed in sexually mature, ovariectomized rats. Bone 15:401-408; 1994.
33. Riggins, R. S., Rucker, R. C., Chan, M. M., Zeman, F., and Beijan, J. R. The effect of fluoride supplementation on the strength of osteopenic bone. Clin Orthop Rel Res 114:352-357; 1976.
34. Riggs, B. L., Hodgson, S. F., O'Fallon, W. M., Chao, E. Y. S., Wahner, H. W., Muhs, J. M., Cedel, S. L., and Melton, L. J., III. Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis. N Engl J Med 322:802-809; 1990.
35. Schnitzler, C. M., Wing, J. R., Gear, K. A., and Robson, H. J. Bone fragility of the peripheral skeleton during fluoride therapy for osteoporosis. Clin Orthop Rel Res 261:268-275; 1990.
36. Søgaard, C. H. Antiresorptive therapy, anabolic therapy, and exercise: Effects on bone mass, structure, and strength - assessed in a rat model. Prevention and treatment of osteoporosis. Danish Med Bull 42:207-208; 1995.
37. Søgaard, C. H., Danielsen, C. C., Thorling, E. B., and Mosekilde, Li. Longterm exercise of young and adult female rats: Effect on femoral neck biomechanical competence and bone structure. J Bone Miner Res 9:409-416; 1994.
38. Søgaard, C. H., Mosekilde, Li., Richards, A., and Mosekilde, Le. Marked decrease in trabecular bone quality after five years of sodium fluoride therapy - assessed by biomechanical testing of iliac crest bone biopsies in osteoporotic patients. Bone 15:393-399; 1994.
39. Søgaard, C. H., Mosekilde, Li., Schwartz, W., Leidig, G., Minne, H. W., and Ziegler, R. Effects of fluoride on rat vertebral body biomechanical competence and bone mass. Bone 16:163-169; 1995.
40. Søgaard, C. H., Wronski, T. J., McOsker, J. E., and Mosekilde, Li. The positive effect of parathyroid hormone on femoral neck bone strength in ovariectomized rats is more pronounced than that of estrogen and bisphosphonates. Endocrinology 134:650-657; 1994.
41. Tam, C. S., Heersche, J. N. M., Murray, T. M., and Parsons, J. A. Parathyroid hormone stimulates the bone apposition rate independently of its resorptive action: Differential effects of intermittent and continuous administration. Endocrinology 110:506-512; 1982.
42. Turner, C. H., Akhter, M. P., and Heaney, R. P. The effects of fluoridated water on bone strength. J Orthop Res 10:581-587; 1992.
43. Turner, C. H., Boivin, G., and Meunier, P. J. A mathematical model for fluoride uptake by the skeleton. Calcif Tissue Int 52:130-138; 1993.
44. Turner, C. H. and Dunipace, A. J. On fluoride and bone strength [letter to the editor]. Calcif Tissue Int 53:289-290; 1993.
45. Turner, C. H. and Dunipace, A. J. On fluoride and bone strength [reply]. Calcif Tissue Int 56:415-418; 1995.
46. 2 for five years. Bone 12:33-37; 1991.
47. Wronski, T. J., Cintron, M., and Dann, L. M. Temporal relationship between bone loss and increased bone turnover in ovariectomized rats. Calcif Tissue Int 43:179-183; 1988.
48. Wronski, T. J. and Yen, C.-F. Anabolic effects of parathyroid hormone on cortical bone in ovariectomized rats. Bone 15:51-58; 1994.
49. Wronski, T. J., Yen, C.-F., Qi, H., and Dann, L. M. Parathyroid hormone is more effective than estrogen or bisphosphonates for restoration of lost bone mass in ovariectomized rats. Endocrinology 132:823-831; 1993.